Han Kun advises on the listing of Broncus Holding Corporation on the Main Board of the Hong Kong Stock Exchange
September, 2021 - Beijing, Mainland China
Han Kun Law Offices has provided legal services in connection with Broncus Holdings Corporation's (Stock Code: 2216) listing and public offering on the Main Board of the Hong Kong Stock Exchange as the PRC counsel to the joint sponsors and the underwriters.
Broncus is a medical device company focused on the development of interventional pulmonology products. Founded in 2012, Broncus is a pioneer in the field of interventional pulmonology, providing innovative lung solutions in China and globally. Leveraging its whole lung access navigation technology and encompassing navigation, diagnosis and treatment, Broncus' integrated interventional pulmonology platform addresses the pain points of the existing diagnosis and treatment paradigms and significant unmet medical needs for lung diseases by improving the diagnosis and treatment effects of lung cancer and chronic obstructive pulmonary disease.
